Beyer, Marc <br/><br/>
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.  [electronic resource] 

 -  Blood  Sep 2005 
 - 2018-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2005-02-0642  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD<br/>Antigens, Differentiation<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CTLA-4 Antigen<br/>Case-Control Studies<br/>DNA-Binding Proteins<br/>Forkhead Transcription Factors<br/>Glucocorticoid-Induced TNFR-Related Protein<br/>Humans<br/>Interleukin-10<br/>L-Selectin<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Middle Aged<br/>Receptors, Interleukin-2<br/>Receptors, Nerve Growth Factor<br/>Receptors, Tumor Necrosis Factor<br/>T-Lymphocyte Subsets--drug effects<br/>Transforming Growth Factor beta<br/>Transforming Growth Factor beta1<br/>Vidarabine--analogs & derivatives